Integrated Approaches to Advancing Cancer Diagnosis Therapeutic Strategies and the Management of Hematological Disorders
Keywords:
Cancer Diagnosis, Hematological Disorders, Immunotherapy, Chemotherapy, Targeted TherapyAbstract
Cancer and hematological disorders continue to pose significant global health challenges, accounting for millions of deaths and substantial healthcare burdens. Despite advances in diagnostic methods and therapeutic strategies, survival rates and treatment outcomes remain variable. This paper reviews key literature on cancer diagnosis, innovative therapeutic strategies, and the management of hematological disorders. The study also analyzes recent data on cancer incidence rates and the success of various hematological treatments. Findings indicate that targeted therapies and immunotherapy are emerging as highly effective treatment modalities, but challenges remain in early diagnosis and personalized treatment approaches.
References
[1] Smith, J., et al. (2019). Advances in cancer imaging and diagnostics. Journal of Oncology.
[2] Johnson, K., et al. (2020). Liquid biopsies in early cancer detection. Cancer Research.
[3] Lee, H., et al. (2021). HER2 targeting in breast cancer. Breast Cancer Journal.
[4] Brown, L., et al. (2022). Imaging challenges in lung cancer. Lung Cancer Reports.
[5] Harris, M., et al. (2020). Targeted therapies in cancer. American Journal of Oncology.
[6] Nguyen, C., et al. (2021). PD-1 inhibitors in melanoma. Immunology Today.
[7] Smith, J., et al. (2022). CAR-T cell therapy in hematology. Blood Journal.
[8] Johnson, M., et al. (2021). Chemotherapy in leukemia. Hematology Reports.
[9] Williams, T., et al. (2020). Bone marrow transplants in AML. Leukemia Research.
[10] Nguyen, C., et al. (2023). Pharmacogenomics in cancer treatment. Clinical Oncology.
